vs
林德（LIN）与Lakeside Holding Ltd（LSH）财务数据对比。点击上方公司名可切换其他公司
林德的季度营收约是Lakeside Holding Ltd的1.3倍（$8.8M vs $7.0M），Lakeside Holding Ltd同比增速更快（95.0% vs 8.2%）
林德是全球知名跨国化工企业，按市场份额及营收计为全球最大工业气体供应商。公司1879年由德国科学家、工程师卡尔·冯·林德在德国威斯巴登创立，现总部位于英国沃金，在爱尔兰注册，2018年由原林德股份公司与1907年在美国成立的普莱克斯合并组建。
莱克赛德出版社是位于美国芝加哥的出版品牌，由RR唐纳利公司运营。该社除了出版高品质书籍外，还承印邮购目录、电话号码簿、百科全书与广告宣传品，最为人熟知的是为芝加哥卡克斯顿俱乐部出版的高端版本，以及经典重印丛书《莱克赛德经典》。
LIN vs LSH — 直观对比
营收规模更大
LIN
是对方的1.3倍
$7.0M
营收增速更快
LSH
高出86.8%
8.2%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.8M | $7.0M |
| 净利润 | — | $-1.6M |
| 毛利率 | 48.5% | 27.2% |
| 营业利润率 | 27.8% | -21.3% |
| 净利率 | — | -22.6% |
| 营收同比 | 8.2% | 95.0% |
| 净利润同比 | — | 18.7% |
| 每股收益（稀释后） | $3.98 | $-0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LINLSH
| Q1 26 | $8.8M | — | ||
| Q4 25 | $8.8B | $7.0M | ||
| Q3 25 | $8.6B | $6.1M | ||
| Q2 25 | $8.5B | $6.3M | ||
| Q1 25 | $8.1B | $3.8M | ||
| Q4 24 | $8.3B | $3.6M | ||
| Q3 24 | $8.4B | $4.1M | ||
| Q2 24 | $8.3B | — |
净利润LINLSH
| Q1 26 | — | — | ||
| Q4 25 | $1.5B | $-1.6M | ||
| Q3 25 | $1.9B | $-1.4M | ||
| Q2 25 | $1.8B | $-893.1K | ||
| Q1 25 | $1.7B | $-1.1M | ||
| Q4 24 | $1.7B | $-1.9M | ||
| Q3 24 | $1.6B | $-1.3M | ||
| Q2 24 | $1.7B | — |
毛利率LINLSH
| Q1 26 | 48.5% | — | ||
| Q4 25 | — | 27.2% | ||
| Q3 25 | — | 18.2% | ||
| Q2 25 | — | 26.7% | ||
| Q1 25 | — | 18.8% | ||
| Q4 24 | — | -1.2% | ||
| Q3 24 | — | 12.8% | ||
| Q2 24 | — | — |
营业利润率LINLSH
| Q1 26 | 27.8% | — | ||
| Q4 25 | 23.0% | -21.3% | ||
| Q3 25 | 27.5% | -20.8% | ||
| Q2 25 | 27.7% | -8.9% | ||
| Q1 25 | 26.9% | -28.2% | ||
| Q4 24 | 27.4% | -55.6% | ||
| Q3 24 | 25.0% | -32.5% | ||
| Q2 24 | 26.4% | — |
净利率LINLSH
| Q1 26 | — | — | ||
| Q4 25 | 17.5% | -22.6% | ||
| Q3 25 | 22.4% | -22.2% | ||
| Q2 25 | 20.8% | -14.2% | ||
| Q1 25 | 20.6% | -28.2% | ||
| Q4 24 | 20.8% | -54.1% | ||
| Q3 24 | 18.5% | -32.7% | ||
| Q2 24 | 20.1% | — |
每股收益（稀释后）LINLSH
| Q1 26 | $3.98 | — | ||
| Q4 25 | $3.28 | $-0.08 | ||
| Q3 25 | $4.09 | $-0.09 | ||
| Q2 25 | $3.73 | $-0.11 | ||
| Q1 25 | $3.51 | $-0.14 | ||
| Q4 24 | $3.61 | $-0.26 | ||
| Q3 24 | $3.22 | $-0.18 | ||
| Q2 24 | $3.44 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.0M | $1.6M |
| 总债务越低越好 | $24.7M | $2.4M |
| 股东权益账面价值 | $40.1M | $12.2M |
| 总资产 | $86.3M | $24.3M |
| 负债/权益比越低杠杆越低 | 0.62× | 0.20× |
8季度趋势，按日历期对齐
现金及短期投资LINLSH
| Q1 26 | $4.0M | — | ||
| Q4 25 | $5.1B | $1.6M | ||
| Q3 25 | $4.5B | $4.5M | ||
| Q2 25 | $4.8B | $5.0M | ||
| Q1 25 | $5.3B | $1.5M | ||
| Q4 24 | $4.8B | $1.1M | ||
| Q3 24 | $5.2B | $2.7M | ||
| Q2 24 | $4.6B | — |
总债务LINLSH
| Q1 26 | $24.7M | — | ||
| Q4 25 | $20.7B | $2.4M | ||
| Q3 25 | $18.6B | $2.4M | ||
| Q2 25 | $19.7B | $1.4M | ||
| Q1 25 | $17.6B | $774.2K | ||
| Q4 24 | $15.3B | $784.8K | ||
| Q3 24 | $17.5B | $589.9K | ||
| Q2 24 | $16.9B | — |
股东权益LINLSH
| Q1 26 | $40.1M | — | ||
| Q4 25 | $38.2B | $12.2M | ||
| Q3 25 | $38.6B | $7.0M | ||
| Q2 25 | $38.5B | $2.8M | ||
| Q1 25 | $38.0B | $749.8K | ||
| Q4 24 | $38.1B | $1.6M | ||
| Q3 24 | $39.2B | $3.6M | ||
| Q2 24 | $38.2B | — |
总资产LINLSH
| Q1 26 | $86.3M | — | ||
| Q4 25 | $86.8B | $24.3M | ||
| Q3 25 | $86.0B | $18.6M | ||
| Q2 25 | $86.1B | $14.4M | ||
| Q1 25 | $82.7B | $9.9M | ||
| Q4 24 | $80.1B | $9.8M | ||
| Q3 24 | $82.5B | $10.8M | ||
| Q2 24 | $80.2B | — |
负债/权益比LINLSH
| Q1 26 | 0.62× | — | ||
| Q4 25 | 0.54× | 0.20× | ||
| Q3 25 | 0.48× | 0.35× | ||
| Q2 25 | 0.51× | 0.48× | ||
| Q1 25 | 0.46× | 1.03× | ||
| Q4 24 | 0.40× | 0.48× | ||
| Q3 24 | 0.45× | 0.16× | ||
| Q2 24 | 0.44× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-453.5K |
| 自由现金流经营现金流 - 资本支出 | $898.0K | — |
| 自由现金流率自由现金流/营收 | 10.2% | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $4.2B | — |
8季度趋势，按日历期对齐
经营现金流LINLSH
| Q1 26 | — | — | ||
| Q4 25 | $3.0B | $-453.5K | ||
| Q3 25 | $2.9B | $-4.0M | ||
| Q2 25 | $2.2B | $-483.7K | ||
| Q1 25 | $2.2B | $-238.3K | ||
| Q4 24 | $2.8B | $-530.2K | ||
| Q3 24 | $2.7B | $-1.4M | ||
| Q2 24 | $1.9B | — |
自由现金流LINLSH
| Q1 26 | $898.0K | — | ||
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.7B | — | ||
| Q2 25 | $954.0M | $-497.4K | ||
| Q1 25 | $891.0M | — | ||
| Q4 24 | $1.6B | $-560.5K | ||
| Q3 24 | $1.7B | $-1.4M | ||
| Q2 24 | $796.0M | — |
自由现金流率LINLSH
| Q1 26 | 10.2% | — | ||
| Q4 25 | 17.9% | — | ||
| Q3 25 | 19.4% | — | ||
| Q2 25 | 11.2% | -7.9% | ||
| Q1 25 | 11.0% | — | ||
| Q4 24 | 18.8% | -15.6% | ||
| Q3 24 | 19.9% | -34.5% | ||
| Q2 24 | 9.6% | — |
资本支出强度LINLSH
| Q1 26 | — | — | ||
| Q4 25 | 16.6% | — | ||
| Q3 25 | 14.8% | — | ||
| Q2 25 | 14.8% | 0.2% | ||
| Q1 25 | 15.7% | 0.0% | ||
| Q4 24 | 15.1% | 0.8% | ||
| Q3 24 | 12.8% | 0.1% | ||
| Q2 24 | 13.7% | — |
现金转化率LINLSH
| Q1 26 | — | — | ||
| Q4 25 | 1.98× | — | ||
| Q3 25 | 1.53× | — | ||
| Q2 25 | 1.25× | — | ||
| Q1 25 | 1.29× | — | ||
| Q4 24 | 1.63× | — | ||
| Q3 24 | 1.76× | — | ||
| Q2 24 | 1.16× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LIN
暂无分部数据
LSH
| Transferred Over Time | $4.6M | 65% |
| Distribution Of Pharmaceutical Products | $2.4M | 35% |
